The oral antiviral therapy PF-07321332 is designed to block the activity of the SARS-CoV-2-3CL protease, an enzyme the coronavirus needs to replicate.  It is administered together with low dose ritonavir, used in some treatments for HIV and hepatitis C.  Landmark agreement  The agreement will allow the UN-backed Medicines Patent Pool (MPP) to sub-license PF-07321332 for production and distribution by qualified… Read More

And according to the fourth WHO global tobacco trends report, that number is expected to continue to drop to 1.27 billion by 2025.    Sixty countries are now on track to achieving the voluntary global target of a 30% per cent reduction by 2025, an increase from two years ago, when only 32 countries were on course.  Encouraging news  For WHO Director-General Tedros Ghebreyesus, the numbers are very encouraging, but more work must be done.  “We still have a long way… Read More

The low cost is possible thanks to a new partnership between the Clinton Health Access Initiative (CHAI), MedAccess and SD Biosensor.  Each year, around 1.3 million women living with HIV become pregnant and just under one million pregnant women are infected with syphilis.    Despite affordable diagnostics and treatment being available, undiagnosed and untreated infections continue to affect the lives of many mothers and their children.  An exciting development  According to WHO, the rapid diagnostic… Read More